Skip to main content
Clinical Trials/NCT07406919
NCT07406919
Not yet recruiting
Not Applicable

Pragmatic Randomized Clinical Trial of AI-Assisted Telemedicine to Improve Diagnostic Accuracy Among Primary Care Physicians in El Salvador

Hospital El Salvador1 site in 1 country180 target enrollmentStarted: February 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Hospital El Salvador
Enrollment
180
Locations
1
Primary Endpoint
Diagnostic Accuracy

Overview

Brief Summary

The goal of this clinical trial is to learn whether access to an artificial intelligence (AI) clinical decision support assistant can improve diagnostic accuracy during real-world telemedicine consultations among primary care physicians in El Salvador.

The main questions it aims to answer are:

  • Does access to the AI assistant increase the proportion of correct diagnoses compared to telemedicine without AI assistance?
  • Does the effect of the AI assistant differ according to the physician's prior experience using AI in telemedicine?

Researchers will compare physicians with the AI assistant enabled to physicians with the AI assistant temporarily disabled to see if access to AI improves diagnostic accuracy.

Participants (physicians) will:

  • Provide telemedicine consultations as part of their routine clinical duties.
  • Be randomly assigned to either have the AI assistant enabled or disabled during the study period.
  • Continue documenting clinical encounters in the electronic platform as usual.
  • Have their anonymized consultation notes reviewed by an independent expert panel to determine diagnostic accuracy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Must be a physician employed by the DoctorSV telemedicine program
  • Must provide written informed consent to participate in the study
  • Consultations must be for acute pathologies of the digestive, respiratory, or urinary systems, or acute ophthalmic infections manageable in primary care
  • Consultation must be the first medical contact (first visit) for the current acute episode
  • The condition must correspond to specific ICD-11 codes defined in the study protocol

Exclusion Criteria

  • Physicians who are inactive on the platform for more than 4 consecutive weeks
  • Physicians who transition to work modalities other than telemedicine or reduce their working hours to less than 20 hours per week
  • Physicians whose employment contract ends (resignation, dismissal, or contract completion) during the data collection period
  • Consultations classified by the physician as requiring immediate in-person attention
  • Consultations requiring referral to another level of care or specialty for definitive management
  • Consultations interrupted or incomplete due to connectivity or system failures
  • Consultations solely for administrative purposes (e.g., certificates, repeat prescriptions without clinical evaluation)
  • Consultations that are follow-up visits or controls for a previously evaluated episode

Arms & Interventions

AI Disabled (Standard Telemedicine)

Experimental

Physicians in this arm will conduct telemedicine consultations with the AI assistant features temporarily disabled. They will perform the standard clinical workflow without automated support for history taking or diagnostic suggestions. This arm represents the removal of the AI tool to measure its impact.

Intervention: Standard Telemedicine Workflow (No AI) (Other)

AI Enabled (AI-Assisted Telemedicine)

Active Comparator

Physicians in this arm will conduct telemedicine consultations with full access to the DoctorSV AI assistant.

Intervention: DoctorSV AI Assistant (Device)

Outcomes

Primary Outcomes

Diagnostic Accuracy

Time Frame: Through study completion, ~ 12-16 weeks

The proportion of consultations where the primary diagnosis recorded by the participating physician matches the "gold standard" reference diagnosis. The reference diagnosis is established by a panel of three independent, blinded expert evaluators reviewing the anonymized clinical notes. A diagnosis is considered "correct" (value = 1) if it matches the reference diagnosis within the same clinically equivalent diagnostic group; otherwise, it is considered "incorrect" (value = 0). The analysis will compare the proportion of correct diagnoses between the AI-enabled and AI-disabled arms.

Secondary Outcomes

  • Diagnostic Concordance(Through study completion, ~12-16 weeks)
  • Diagnostic Accuracy Stratified by Physician Experience Level(Through study completion, ~12-16 weeks)
  • Diagnostic Accuracy Stratified by Clinical System(Through study completion, ~12-16 weeks.)

Investigators

Sponsor
Hospital El Salvador
Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials